Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M290,856Revenue $M71,312Net Margin (%)23.3Z-Score5.3
Enterprise Value $M276,354EPS $4.8Operating Margin %28.1F-Score7
P/E(ttm))19.0Cash Flow Per Share $6.2Pre-tax Margin (%)27.7Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %3.5Quick Ratio2.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-0.9Current Ratio2.5Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %9.0ROA % (ttm)15.9Higher Current Ratio y-yY
Dividend Yield %2.6Insider Buy (3m)0ROE % (ttm)28.2Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,820ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJYacktman Focused Fund 2014-09-30 Reduce-0.21%$99.82 - $108.64
($103.64)
$ 103.130%Reduce -6.06%3,100,000
JNJYacktman Fund 2014-09-30 Reduce-0.13%$99.82 - $108.64
($103.64)
$ 103.130%Reduce -3.7%3,900,000
JNJJohn Rogers 2014-06-30 Add0.2%$96.54 - $105.76
($101.02)
$ 103.132%Add 42.46%522,727
JNJRichard Pzena 2014-06-30 Add0.17%$96.54 - $105.76
($101.02)
$ 103.132%Add 33.12%1,155,666
JNJHOTCHKIS & WILEY 2014-06-30 Reduce-0.89%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -63.73%1,426,614
JNJYacktman Focused Fund 2014-06-30 Reduce-0.51%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -13.16%3,300,000
JNJRobert Olstein 2014-06-30 Reduce-0.31%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -20.91%87,000
JNJDonald Yacktman 2014-06-30 Reduce-0.21%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -5.5%9,045,902
JNJTweedy Browne 2014-06-30 Reduce-0.17%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -1.71%4,196,224
JNJRay Dalio 2014-06-30 Reduce-0.16%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -74.94%65,893
JNJGeorge Soros 2014-06-30 Reduce-0.05%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -51.22%50,000
JNJJohn Hussman 2014-06-30 Reduce-0.01%$96.54 - $105.76
($101.02)
$ 103.132%Reduce -50%1,325
JNJJoel Greenblatt 2014-06-30 Sold Out -0.01%$96.54 - $105.76
($101.02)
$ 103.132%Sold Out0
JNJRobert Olstein 2014-03-31 Add0.26%$86.62 - $97.44
($92.6)
$ 103.1311%Add 20.88%110,000
JNJRay Dalio 2014-03-31 Add0.12%$86.62 - $97.44
($92.6)
$ 103.1311%Add 132.34%262,993
JNJGeorge Soros 2014-03-31 Buy 0.1%$86.62 - $97.44
($92.6)
$ 103.1311%New holding, 102500 sh.102,500
JNJJoel Greenblatt 2014-03-31 Buy 0.01%$86.62 - $97.44
($92.6)
$ 103.1311%New holding, 7496 sh.7,496
JNJJohn Hussman 2014-03-31 Reduce-0.65%$86.62 - $97.44
($92.63)
$ 103.1311%Reduce -97.42%2,650
JNJPRIMECAP Management 2014-03-31 Reduce-0.15%$86.62 - $97.44
($92.6)
$ 103.1311%Reduce -10.14%12,300,986
JNJChris Davis 2014-03-31 Sold Out -0.04%$86.62 - $97.44
($92.6)
$ 103.1311%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JNJ Brian Rogers 2014-09-304,633,0000.161.8
JNJ Yacktman Fund 2014-09-303,900,0000.143.6-3.7%
JNJ Yacktman Focused Fund 2014-09-303,100,0000.113.5-6.06%
JNJ John Rogers 2014-06-30522,7270.020.67+42.46%
JNJ Richard Pzena 2014-06-301,155,6660.040.67+33.12%
JNJ Ken Fisher 2014-06-3010,448,4480.372.3+4.72%
JNJ James Barrow 2014-06-3017,065,2300.612.4+0.66%
JNJ Jean-Marie Eveillard 2014-06-301,623,4820.060.41+0.37%
JNJ Ruane Cunniff 2014-06-3076,01200.04+0.29%
JNJ Yacktman Fund 2014-06-304,050,0000.143.6
JNJ Brian Rogers 2014-06-304,633,0000.161.7
JNJ Richard Snow 2014-06-303,24500.01
JNJ Michael Price 2014-06-3035,00000.45
JNJ Tom Gayner 2014-06-30574,2000.021.7
JNJ Dodge & Cox 2014-06-3038,62500
JNJ Richard Perry 2014-06-30342,2770.010.99
JNJ Warren Buffett 2014-06-30327,1000.010.03
JNJ Prem Watsa 2014-06-3084,70000.61
JNJ PRIMECAP Management 2014-06-3012,242,4200.431.4-0.48%
JNJ Tweedy Browne 2014-06-304,196,2240.159.4-1.71%
JNJ Donald Yacktman 2014-06-309,045,9020.323.8-5.5%
JNJ Mario Gabelli 2014-06-30373,1860.010.2-5.54%
JNJ Yacktman Focused Fund 2014-06-303,300,0000.123.5-13.16%
JNJ Robert Olstein 2014-06-3087,00001.2-20.91%
JNJ John Hussman 2014-06-301,32500.01-50%
JNJ George Soros 2014-06-3050,00000.04-51.22%
JNJ HOTCHKIS & WILEY 2014-06-301,426,6140.050.53-63.73%
JNJ Ray Dalio 2014-06-3065,89300.05-74.94%
JNJ Joel Greenblatt 2014-06-30000Sold Out
JNJ Mark Hillman 2013-12-3130,74604.2-0.27%
JNJ Meridian Funds 2013-06-307,88500.03
Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-1.43view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-1.6view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.052.58view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.1510.18view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.3912.3view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.689.55view
Stoffels PaulusChief Scientific Officer 2013-07-25Sell45,440$92.411.07view
Caruso Dominic JVP, Finance; CFO 2013-07-18Sell30,000$90.3113.64view
CULLEN JAMESDirector 2013-05-07Sell4,929$85.420.18view
LINDQUIST SUSAN LDirector 2012-12-07Sell7,600$70.0246.57view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    3M the Cash Generation Machine in the Industrials Segment Oct 23 2014 
    Dividend Aristocrats In Focus Part 24: Consolidated Edison Oct 22 2014 
    Bill Frels Comments on Johnson & Johnson Oct 20 2014 
    Bill Frels' Mairs & Power Growth Fund Q3 2014 Commentary Oct 20 2014 
    What Have We Really Lost? Oct 20 2014 
    The Key Drivers For Johnson & Johnson Oct 15 2014 
    Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Ch Oct 15 2014 
    Don't Forget: Buy And Hold Is Not Buy And Forget Oct 14 2014 
    Sure Bets: Slow-Changing Industries for Long-Term Investors Oct 01 2014 
    "A Unique Period of Time," Revisited Sep 22 2014 

    More From Our Partners
    What Have We Really Lost? Oct 20 2014 - SEEKINGALPHA

    More From Other Websites
    [$$] J&J Unit Wins Texas Suit Regarding All-Metal Hip Implant Oct 23 2014
    Johnson & Johnson Wins First Pinnacle Hip Implant Trial Oct 23 2014
    Johnson & Johnson's DePuy wins first trial over Pinnacle hips Oct 23 2014
    Drugmakers want indemnity Oct 23 2014
    Drugmakers may need indemnity for fast-tracked Ebola vaccines Oct 23 2014
    How Dick Cheney Joined the Fight Against Ebola Without Even Trying Oct 22 2014
    U.S. tightens Ebola monitoring for West African visitors Oct 22 2014
    P&G loses North American head, beauty exec Oct 22 2014
    GSK expects first doses of Ebola vaccine ready by year end Oct 22 2014
    [video] Johnson & Johnson to Work on Ebola Vaccine and More Oct 22 2014
    [video]J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials By May Oct 22 2014
    [video] Stoffels Says J&J Racing to Develop Ebola Vaccine (Video) Oct 22 2014
    [video] J&J Gets Ready to Test Ebola Vaccine Oct 22 2014
    Johnson & Johnson to begin testing Ebola vaccine in January Oct 22 2014
    Boeing profits flying high; Yahoo jumps on beat; J&J working on Ebola vaccine Oct 22 2014
    [$$] Johnson & Johnson to Begin Testing Ebola Vaccine in January Oct 22 2014
    Johnson & Johnson plans Ebola vaccine testing Oct 22 2014
    Johnson & Johnson plans Ebola vaccine testing Oct 22 2014
    [video] Ebola Vaccine Trials to Start in Africa by January Oct 22 2014
    Why Johnson & Johnson (JNJ) Stock Is Higher Today Oct 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK